Business description
United Therapeutics Corporation is a biotechnology company focused on the development and commercialization of innovative products to address the unmet medical needs of patients with chronic and life-threatening cardiovascular and infectious diseases and cancer.
Management board & Supervisory board
| CEO |
| Dr. Martine A. Rothblatt |
| Management board |
| James C. Edgemond, Michael Benkowitz, Paul A. Mahon |
| Supervisory board |
| Dr. Martine A. Rothblatt, Christopher Causey, Christopher Patusky, Dr. Judy D. Olian, Linda Maxwell, M.D., Louis Sullivan, Nilda Mesa, Prof. Raymond Dwek, Ray Kurzweil, Richard Giltner, Tommy G. Thompson, Jan Malcolm |
Company data
| Name: |
United Therapeutics Corporation |
| Address: |
1000 Spring Street,Silver Spring, Maryland 20910, USA |
| Phone: |
+1-301-608-9292 |
| Fax: |
- |
| E-mail: |
-
|
| Internet: |
https://www.unither.com/index |
| Industry: |
Biotechnology |
| Sector: |
Biotechnology |
| Sub sector: |
Biotechnology |
| End of financial year: |
31/12 |
| Free Float: |
- |
| IPO date: |
17/06/1999 |
Investor relations
| Name: |
- |
| IR phone: |
+1-301-608-9292 |
| IR Fax: |
- |
| IR e-mail: |
-
|
